Raygent.com Business Development And Intelligence For Healthcare Markets
  • Home
  • Buzzwords
  • About Us
  • Articles
    • Genomics Part II-Diagnostics take center stage
    • Alzheimer’s Disease
    • Recession Fears trumped by higher crude and supply disruptions
    • 2008 GEN Wall Street RoundUp
    • 2007 Energy Blog
    • Biotech Gen August 2007
    • Biotechnology 2007
    • Cancer Vaccines
    • Emerging Biopharmaceutical
    • Molecular DX
    • Investing in Health Care
    • Diabetes
    • American Society of Clinical Oncology 2005
    • Investing in Biotech
    • Waxman
    • Rag 2005
    • 2009 Biopharmaceutical Portfolio
    • Lockdown-Mode Paralyzes Bioindustry
    • Buzzwords 1/31/12 “Vaporized”
    • Real Estate Advisory Group 10-09-2005
    • RAG-Real Estate Advisory Group
    • Biopharmaceutical Stock
    • Fidelity Biotech Fund (FBIOX) up 7.9% YTD Outperforms Major ETFs
  • Archives
  • Contact Us

Find Us Online:

  • BIOgraph
  • Biopharmaceuticals Portfolio
    • 2011 Rayno Biopharmaceuticals Portfolio
  • Diagnostics and Tools Portfolio
    • 2011 Rayno Tools and Diagnostics Portfolio
  • Life Science ETF's and Mutual Funds
    • 2009-2010 Life Science Portfolios
  • Other
    • Company Profiles
    • Energy
    • Macro
    • RAG
    • Weather
  • Reading List

Articles

  • Genomic Testing
  • Alzheimers Disease
  • Recession Fears trumped by higher crude and supply disruptions
  • 2008 GEN Wall Street RoundUp
  • 2007 Energy Blog
  • Biotech Gen August 2007
  • Biotechnology 2007
  • Cancer Vaccines
  • Emerging Biopharmaceuticals
  • Molecular DX
  • Investing in Health Care
  • Diabetes
  • Real Estate Advisory Group 10-9-2005
  • RAG-Real Estate Advisory Group
  • Buzzwords
  • American Society of Clinical Oncology 2005
  • Investing In Biotech
  • Biopharmaceutical Stock
  • Waxman
  • RAG 2005
  • 2009 Biopharmaceutical Portfolio
  • Lockdown-Mode Paralyzes Bioindustry

Search

  • Latest
  • Popular
  • Tags
  • Another Daily Reversal : Take More Off in Biotech February 21, 2012
  • Gilead (GILD $46.50) off 15% on Hep-C Clinical Data -Viral Relapse Seen February 17, 2012
  • No Panic Just Take A Little Off:Caution- Update Rally 2/16 February 15, 2012
  • Rayno Life Science Portfolio Racks-Up More Gains: REGN, RGDX, SRLS February 13, 2012
  • Response Genetics Raises $7.5M at $1.50 with New CEO February 2, 2012
  • Rayno Life Science Tools And Dx Portfolio Update:Immucor Beats 6/20 update April 6, 2011
  • Three Small Cap Stocks for a Rebound in January: AMRI,ASTX,SRLS-UPDATE 1/5/12 December 14, 2011
  • Another Big Rally on Europe Non-News: Biotech Sector Lagging October 18, 2011
  • Rayno 2009 Biotechnology Portfolio-Mid Year Update July 13, 2009
  • JPMorgan Healthcare Conference-2010 Day One-Monday January 11 January 12, 2010
AACC AACC Effect AACR active cellular immunotherapy ADC antibody-drug conjugates Add new tag Alzheimer Disease antibiotics antibody-drug conjugates antisense antiviral ASCO B2-microglobulin BATTLE Trial bearish nat gas market biodiscovery BIO ETF's biogenerics BIOgraph biomarkers biomedical biosimilars Biotech ETF's biotechnology sector biotech portfolios and ETFs biotech stocks blood transfusion demand BLUD BMY C.difficile cancer vaccines immunotherapy clinical diagnostics companion diagnostics diagnostics genomics genomics personalized medicine genzyme GILD healthcare reform life science ETF's mass spec molecular diagnostics personalized medicine pharmacogenomics targeted therapy

RSS Reuters Healthcare

  • UPDATE 2-Prevnar trial results needed for CDC recommendation
  • UPDATE 1-Sequenom seeks injunction in Aria patent case
  • Obama's Alzheimer's plan focuses on treatment, care
  • UPDATE 3-Express Scripts 4th-qtr profit lower than expected

About the Author

Rod Raynovich is the founder of Raygent Associates, a management consulting firm providing business development and strategic marketing services in the life science and medical device area. He publishes his thoughts and analysis on the biotech industry at www.raygent.com.

Read More

Raygent Reads

  • Bloomberg – Business & Financial News, Breaking News Headlines
  • GEN | Genetic Engineering & Biotechnology News – Biotech from Bench to Business
  • GenomeWeb
  • Investor Uprising – The Individual Investor Intelligence Network
  • ZeroHedge

Copyright © 2009-2011 Raygent

Raygent Associates  |  PO Box 3701 Manhattan Beach, CA 90266  |  Phone 1-(310)-871-1231  |  rod@rayno.com